Literature DB >> 22998402

Changes in the Oswestry Disability Index that predict improvement after lumbar fusion.

Mladen Djurasovic1, Steven D Glassman, John R Dimar, Charles H Crawford, Kelly R Bratcher, Leah Y Carreon.   

Abstract

OBJECT: Clinical studies use both disease-specific and generic health outcomes measures. Disease-specific measures focus on health domains most relevant to the clinical population, while generic measures assess overall health-related quality of life. There is little information about which domains of the Oswestry Disability Index (ODI) are most important in determining improvement in overall health-related quality of life, as measured by the 36-Item Short Form Health Survey (SF-36), after lumbar spinal fusion. The objective of the study is to determine which clinical elements assessed by the ODI most influence improvement of overall health-related quality of life.
METHODS: A single tertiary spine center database was used to identify patients undergoing lumbar fusion for standard degenerative indications. Patients with complete preoperative and 2-year outcomes measures were included. Pearson correlation was used to assess the relationship between improvement in each item of the ODI with improvement in the SF-36 physical component summary (PCS) score, as well as achievement of the SF-36 PCS minimum clinically important difference (MCID). Multivariate regression modeling was used to examine which items of the ODI best predicted achievement for the SF-36 PCS MCID. The effect size and standardized response mean were calculated for each of the items of the ODI.
RESULTS: A total of 1104 patients met inclusion criteria (674 female and 430 male patients). The mean age at surgery was 57 years. All items of the ODI showed significant correlations with the change in SF-36 PCS score and achievement of MCID for the SF-36 PCS, but only pain intensity, walking, and social life had r values > 0.4 reflecting moderate correlation. These 3 variables were also the dimensions that were independent predictors of the SF-36 PCS, and they were the only dimensions that had effect sizes and standardized response means that were moderate to large.
CONCLUSIONS: Of the health dimensions measured by the ODI, pain intensity, walking, and social life best predicted improvement in overall health-related quality of life, as measured using the SF-36 PCS.

Entities:  

Mesh:

Year:  2012        PMID: 22998402     DOI: 10.3171/2012.8.SPINE12614

Source DB:  PubMed          Journal:  J Neurosurg Spine        ISSN: 1547-5646


  5 in total

1.  Prospective investigation of Oswestry Disability Index and short form 36 subscale scores related to sagittal and coronal parameters in patients with degenerative lumbar scoliosis.

Authors:  Chang-Hoon Jeon; Nam-Su Chung; Hee-Woong Chung; Ha Seung Yoon; Han-Dong Lee
Journal:  Eur Spine J       Date:  2021-03-14       Impact factor: 3.134

2.  Telephone-Based Intervention to Improve Rehabilitation Engagement After Spinal Stenosis Surgery: A Prospective Lagged Controlled Trial.

Authors:  Richard L Skolasky; Anica M Maggard; Stephen T Wegener; Lee H Riley
Journal:  J Bone Joint Surg Am       Date:  2018-01-03       Impact factor: 5.284

3.  Influence of Gender on Health-Related Quality of Life and Disability at 1 Year After Surgery for Thoracolumbar Burst Fractures.

Authors:  Tiberiu Maior; Gheorghe Ungureanu; Cristian Kakucs; Cristian Berce; Bobe Petrushev; Ioan-Stefan Florian
Journal:  Global Spine J       Date:  2017-07-07

4.  Gender Differences in the Self-assessment of Quality of Life and Disability After Spinal Fusion for Chronic Low Back Pain at a Neurosurgical Center in Eastern Europe.

Authors:  Gheorghe Ungureanu; Alexandra Chitu; Ioana Iancu; Cristian Kakucs; Tiberiu Maior; Ioan Stefan Florian
Journal:  Neurospine       Date:  2018-08-29

5.  Lumbar Spine Fusion Patients' Use of an Internet Support Group: Mixed Methods Study.

Authors:  Janni Strøm; Mette Terp Høybye; Malene Laursen; Lene Bastrup Jørgensen; Claus Vinther Nielsen
Journal:  J Med Internet Res       Date:  2019-07-04       Impact factor: 5.428

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.